Viewing Study NCT00086658


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-01-02 @ 11:19 PM
Study NCT ID: NCT00086658
Status: COMPLETED
Last Update Posted: 2020-05-05
First Post: 2004-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module